Key factors in the control of tuberculosis are rapid detection, adequate therapy, and contact tracing to arrest further transmission (4) . Recent developments in DNA technology and molecular biology have led to methods for rapid detection of mycobacterial DNA or RNA in clinical specimens by in vitro nucleic acid amplification (19, 33) . Furthermore, methods have been developed to trace tuberculosis transmission routes by the differentiation of clinical isolates based on polymorphism in genomic DNA of Mycobacterium tuberculosis (25) . However, no methods have been described that allow simultaneous detection and strain differentiation of M. tuberculosis bacteria present in clinical specimens without the need to culture this slowly growing organism. This study was undertaken to develop such a method.
The method most widely used to differentiate M. tuberculosis complex strains is DNA fingerprinting by Southern blotting of genomic DNA by using the mobile element IS6110 as a probe (27) . Other repetitive elements used for strain differentiation are the polymorphic GC-rich sequence PGRS (22) and the triplet multimer (GTG) 5 (32) . Although PCR-based methods have been described to visualize DNA polymorphism in M. tuberculosis complex strains associated with these repetitive DNA elements, the described methods are not suitable for routine simultaneous detection and typing of M. tuberculosis in clinical specimens because of polymorphism in the target for the PCR primers or because of too much variation in the size of the DNA target to be bridged by the primers (11, 20, 21) .
We exploited the previously observed DNA polymorphism within the direct repeat (DR) locus of M. tuberculosis to develop a method to simultaneously detect and type M. tuberculosis. This locus contains multiple, well-conserved 36-bp DRs interspersed with nonrepetitive spacer sequences 34 to 41 bp long (15) (Fig. 1A) . Strains vary in the number of DRs and in the presence or absence of particular spacers (14) . This polymorphism is probably due to homologous recombination between neighboring or distant DRs and to rearrangements driven by the insertion element IS6110, which is present in the DR region of most M. tuberculosis strains (14) . Since the DRs are extremely well conserved among M. tuberculosis strains, each DR copy within the DR locus is a potential target for in vitro PCR amplification. The variation of spacers within the conserved DRs has been used by Groenen et al. (14) to differentiate M. tuberculosis strains by using a PCR-based method; however, this method is not suitable for routine use in a clinical laboratory because the method is technically demanding and it is difficult to obtain a high throughput of samples. Here we describe a novel method, "spoligotyping" (spacer oligotyping), in which the DRs are used as a target for in vitro DNA amplification and in which the variation in the spacers is exploited to obtain different hybridization patterns of the amplified DNA with multiple synthetic spacer oligonucleotides, which are covalently bound to a membrane. We will show that spoligotyping is a simple, rapid, and robust method for simultaneous detection and typing of M. tuberculosis in clinical spec-imens without the need to culture M. tuberculosis or purify DNA.
MATERIALS AND METHODS
Strains and clinical specimens. The laboratory strain M. tuberculosis H37Rv was used to sequence the whole DR region. H37Rv and the Pasteur strain of M. bovis BCG P3 were used as reference strains for spoligotyping. Most of the M. tuberculosis complex strains were obtained from the collection in Bilthoven, where all of the M. tuberculosis complex strains isolated in The Netherlands since 1993 have been routinely typed by IS6110 fingerprinting (27) and tested for drug sensitivity. The M. bovis strains used were also from the collection in Bilthoven and originated from cattle. Sixteen M. tuberculosis strains were from patients involved in three suspected outbreaks in England. One was a community outbreak that comprised five patients from whom M. tuberculosis was isolated between October 1991 and November 1992; four isolates were resistant to isoniazid and streptomycin, and one was resistant to isoniazid alone. Another suspected outbreak involved five patients from a renal unit of a United Kingdom hospital. Contacts among three of the five patients had been demonstrated. The third suspected outbreak in a small town in northern England comprised two staff members of a training center who presented with pulmonary tuberculosis in March 1992 and March 1993, respectively, and a member of the family of one of these staff members who developed tuberculosis 2 years and 4 months after the first patient. Two isolates from patients in the same town served as controls.
The clinical specimens, which were directly subjected to spoligotyping, were obtained from six tuberculosis patients in different hospitals in The Netherlands and from eight patients in St. Mary's Hospital in London.
Fingerprint analysis and spoligotyping. The whole DR region of M. tuberculosis H37Rv was sequenced as part of this study (EMBL accession number Z48304). This was done by using the cosmid T211 (kindly provided by S. Cole, Institut Pasteur, Paris, France), a recombinant plasmid from a cosmid library of M. tuberculosis H37Rv. Only part of the sequence of the DR region of M. bovis BCG is known (15) . The sequenced regions of the DR locus in M. tuberculosis H37Rv and M. bovis BCG are depicted in Fig. 1 . The oligonucleotides DRa and DRb (see Table 1 ) were used as primers to amplify the whole DR region by PCR.
Unless otherwise indicated, approximately 10 ng of genomic mycobacterial DNA purified from cultured cells (28) was used as a target for spoligotyping. DNA extraction from clinical material was done as previously described (17, 18) . Fifty microliters of the following reaction mixture were used for the PCR: Tth buffer (5 mM Tris ⅐ HCl, 5 mM KCl, 0.7 mM MgCl 2 , pH 9.0), each deoxynucleoside triphosphate at 200 mM, 20 pmol each of primers DRa and DRb, 10 ng of DNA, and 0.5 U of Tth polymerase (HT Biotechnology Ltd., Cambridge, United Kingdom). The mixture was heated for 3 min at 96ЊC and subjected to 20 cycles of 1 min at 96ЊC, 1 min at 55ЊC, and 30 s at 72ЊC. For direct amplification of mycobacterial DNA in clinical samples, dTTP was replaced with dUTP and 0.5 U of uracil DNA glycosylase was included in the reaction mixture to avoid contamination with previously amplified DNA (18) . Thermal cycling of the latter samples included 10 min at 40ЊC, 3 min at 95ЊC, and 40 cycles of 1.5 min at 93ЊC, 2 min at 57ЊC, and 3 min at 72ЊC. The amplified product was hybridized to a set of 43 immobilized oligonucleotides, each corresponding to one of the unique spacer DNA sequences within the DR locus. The sequences of the oligonucleotides used are given in Table 1 . These oligonucleotides were covalently bound to a membrane as previously described (16) . In short, a membrane (Biodyne C; Pall Biosupport, Portsmouth, United Kingdom) was activated by using 16% (wt/vol) 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (Sigma). The oligonucleotides were applied to the membrane in parallel by using a miniblotter system (MN45; Immunetics, Cambridge, Mass.). After a short incubation, the membrane was inactivated by using 100 mM NaOH and washed in 2ϫ SSPE (1ϫ SSPE is 0.18 M NaCl, 10 mM NaH 2 PO 4 , and 1 mM EDTA [pH 7.7] ; Gibco BRL Life Technologies, Inc.) supplemented with 0.1% sodium dodecyl sulfate (SDS; Sigma). For hybridization, 20 l of the amplified PCR product was diluted in 150 l of 2ϫ SSPE-0.1% SDS and heat denatured. The diluted samples (130 l) were pipetted into the parallel channels in such a way that the channels of the miniblotter apparatus were perpendicular to the rows of oligonucleotides deposited previously. Hybridization was done for 60 min at 60ЊC. After hybridization, the membrane was washed twice in 250 ml of 2ϫ SSPE-0.5% SDS for 10 min each time at 60ЊC and then incubated in 1:4,000-diluted streptavidin-peroxidase conjugate (Boehringer) for 45 to 60 min at 42ЊC. The membrane was washed twice, for 10 min each time, in 250 ml of 2ϫ SSPE-0.5% SDS at 42ЊC and rinsed with 250 ml of 2ϫ SSPE for 5 min at room temperature. Detection of hybridizing The primers used were DRa (GGTTTTGGGTCTGACGAC, 5Ј biotinylated) and DRb (CCGAGAGGGGACGGAAAC). The numbers of spacer oligonucleotides 1 to 43 correspond to the spacer numbers in Fig. 1 . The order of the spacers on the filter corresponds to their order in the genome. Note that the spoligotype of strains 6, 12, and 37 corresponds to that of strains from the Beijing genotypic group described previously (30) .
DNA was done by using chemiluminescent ECL (Amersham) detection liquid (28, 29) , followed by exposure to X-ray film (Hyperfilm ECL; Amersham) in accordance with the instructions of the manufacturer. For repeated use of membranes, the membranes were stripped by being washed two times for 30 min each time in 1% SDS at 80ЊC and then incubated for 15 min in 20 nM EDTA (pH 8) at room temperature. Membranes were sealed in plastic and stored at 4ЊC until further use.
RESULTS
Simultaneous detection and differentiation of M. tuberculosis. To amplify the whole DR region of M. tuberculosis complex strains by PCR, we used primers DRa and DRb, which allow amplification of the whole DR region, including the interspersed spacers (Fig. 1B) . Because DRa is labeled with biotin, the amplified DNA could be used directly for hybridization to the 43 spacer oligonucleotides, which were covalently bound to a membrane. These spacer oligonucleotides were derived from sequences of the DR regions of M. tuberculosis H37Rv and M. bovis BCG. Because clinical isolates differ in the presence of such spacer sequences, mycobacterial strains can be differentiated by their different hybridization patterns or spoligotypes. Figure 1C illustrates the variability in the hybridization patterns obtained with 34 randomly selected human M. tuberculosis strains isolated in the first half of 1993 and four M. bovis isolates from animals. Most of the strains show different spoligotypes, suggesting that spoligotyping allows good differentiation of the M. tuberculosis complex. To determine the potential of spoligotyping for strain differentiation of M. tuberculosis complex strains, we analyzed 118 randomly selected M. tuberculosis strains isolated in the first half of 1993 by spoligotyping and compared the results with those obtained by IS6110-associated restriction fragment length polymorphism (RFLP), which is the most widely used method of strain differentiation (27) . The different spoligotypes were sorted on the basis of similarity by using a word processor, and the types obtained are schematically depicted in Fig. 2 . Sixty-eight different spoligotypes were distinguished among the 118 M. tuberculosis isolates investigated, whereas 88 IS6110 fingerprint types were found. Compared with IS6110 fingerprinting, strain differentiation by spoligotyping was less successful for strains carrying a high number of IS6110 copies but better for strains with a single or a few IS6110 elements (Table 2 ). This feature of spoligotyping may be valuable for the analysis of strains from geographical regions where strains with a low IS6110 copy number are prevalent and for differentiation of M. bovis, which often contains a single IS6110 element (5, 7).
We tested 35 M. bovis strains by spoligotyping. Nineteen spoligotypes were distinguished, whereas only seven types could be distinguished by IS6110-associated RFLP (Fig. 2 and Table 2 ). Unexpectedly, the absence of the five 3Ј spacers (spacers 39 to 43) in the DR region was characteristic of all of the M. bovis strains, and this feature distinguished M. bovis from all of the M. tuberculosis strains tested. Thus, spoligotyping may not only be useful for differentiation of M. bovis strains but may also be used to distinguish these from M. tuberculosis, a distinction which is often difficult to make by using conventional bacteriological techniques (31) . Sensitivity and specificity of spoligotyping. The sensitivity of the spoligotyping method to detect M. tuberculosis DNA was determined. Ten femtograms of chromosomal M. tuberculosis DNA, an amount corresponding to about two mycobacterial genomes, was reproducibly detectable. Although the average molecular weight of the amplified DNA was found to be dependent on the concentration of target DNA, the hybridization patterns were independent of the target DNA concentration, even when the target corresponded to only two mycobacterial genomes. When the quantity of target DNA for PCR was further decreased, truncated hybridization patterns were often obtained, suggesting that the DR region was broken into two or more separate parts and that single broken molecules were present in the separate vials containing the highly diluted DNA (data not shown).
Preliminary studies (14, 15) have shown that the DR cluster is present only in bacteria belonging to the M. tuberculosis complex group, which includes M. tuberculosis, M. africanum, M. bovis, and M. microti. We have tested the presence of the DR sequence in a variety of other mycobacteria. No amplification or hybridization to spacer oligonucleotides was found by using DNAs from 33 different mycobacterial species not belonging to the M. tuberculosis complex. Furthermore, no amplification or hybridization was found by spoligotyping of 10 gram-positive and 10 gram-negative nonmycobacterial species, confirming the specificity of the DR cluster for M. tuberculosis complex bacteria.
Detection and typing of M. tuberculosis in clinical specimens. The utility of spoligotyping in clinical practice was evaluated when DNA was extracted from sputum and other clinical specimens from five patients whose samples had been found to be smear positive and were later also found to be culture positive. All of these samples were positive by spoligotyping (Fig. 3) . Furthermore, the spoligotypes obtained from the clinical samples were identical to those obtained from the corresponding cultured mycobacteria, indicating that neither the DNA extraction procedure nor contaminants in the DNA extracts of the clinical samples affected the spoligotyping results. Samples from each of these patients showed different spoligotypes, which is consistent with the absence of data supporting an epidemiological link between these patients from the Academic Hospital in Amsterdam. In the same hospital, a presumptive case of BCG-itis was disclosed by spoligotyping. A 3-year-old Turkish child developed severe lymphadenitis 1 year after BCG vaccination. The lymph node biopsy contained M. tuberculosis complex DNA as determined by PCR with IS6110 DNA as the target (17, 18) . Analysis of this sample by spoligotyping showed a hybridization pattern identical to that of M. bovis BCG. Because all of the M. bovis strains isolated from animals and humans have exhibited spoligotypes different from that of M. bovis BCG 4a), these data suggest infection of the child with M. bovis BCG. In St. Mary's Hospital, the utility of spoligotyping in clinical practice was evaluated by testing sputa of eight patients whose samples were smear and culture positive. Six of the eight samples exhibited distinct patterns (Fig. 4, lanes 1 to  4, 6, and 8) . Two of the samples showed virtually identical patterns which differed only slightly in the intensity of a few weak hybridization signals (lane 5 and 7). This result prompted further epidemiological investigations, but no obvious link was found.
Tracing of epidemiologically related tuberculosis infections. To evaluate the usefulness of spoligotyping to trace tuberculosis outbreaks, we typed strains from outbreaks in The Netherlands and the United Kingdom. Strains from four community outbreaks in The Netherlands caused by drug-sensitive M. tuberculosis were investigated. These strains, isolated from epidemiologically related cases, had previously been shown to FIG. 3 . Spoligotyping of M. tuberculosis DNAs isolated from clinical samples from extrapulmonary sites (lanes 1a, 3a, and 4a contained samples from patients with retropharyngeal, neck, and peritoneal abcesses, respectively) and pulmonary tuberculosis patients (lanes 2a, 5a, and 6a) and of DNAs obtained from bacterial cultures of samples of the corresponding patients (the b lanes). The clinical materials were pus (lanes 1a, 3a, and 4a), sputum (lane 2a), bronchoalveolar lavage (lane 5a), and a lung biopsy (lane 6a). DNA was extracted as previously described (16, 17) . 8) and clinical isolates from three outbreaks of tuberculosis in London (lanes 12 to 27). Lanes: 9, negative control; 10, H37Rv; 11, M. bovis BCG; 12 to 16, isolates from a community outbreak of multidrugresistant tuberculosis indicating that the isolates in lanes 12, 14, 15, and 16 are related; 17 to 21, isolates from a hospital outbreak of isoniazid-resistant tuberculosis indicating that isolates 17, 18, and 20 are related; 22 to 27, isolates from a hospital outbreak of drug-sensitive tuberculosis affecting patients and staff indicating that isolates 23, 24, and 26 are related. The presence of a spacer in the M. tuberculosis DNA was inferred when the autoradiograph signal was as dark as that for the equivalent region in one of the controls. have identical IS6110 fingerprints. As shown in Fig. 5 , strains belonging to the same outbreak had identical hybridization patterns. The spoligotype of a single isolate (lane 26) differed from those of the other strains in the same outbreak by the absence of a single spacer. Similarly, slight variations in IS6110 fingerprints have occasionally been found among outbreak strains (6, 26, 28) .
Furthermore, we analyzed strains from three suspected small outbreaks in the United Kingdom. One was a community outbreak caused by isoniazid-and streptomycin-resistant tuberculosis in patients presenting over a 2-year period (Fig. 4,  lanes 12 to 16) . The spoligotypes of the cultured bacteria were identical in four cases (Fig. 4, lanes 12 and 14 to 16) . A fifth isolate from a patient from the community was isoniazid resistant only and showed a different pattern (lane 13). These data confirmed the previously reported identical RFLP patterns of the four identical strains (13) .
Furthermore, suspected transmission of isoniazid-resistant M. tuberculosis among patients in a renal unit of a United Kingdom hospital was investigated (lanes 17 to 21). These patients had been treated prophylactically with isoniazid. Three male patients, one of whom was human immunodeficiency virus (HIV) positive, presented within a 2-month period with pulmonary tuberculosis. The spoligotypes of the strains isolated from these patients revealed similar patterns (Fig. 4,  lanes 17, 18, and 20) . Identical patterns were also observed by RFLP (data not shown). M. tuberculosis isolates from two other patients from the same unit which were not resistant to isoniazid showed different spoligotypes (Fig. 4, lanes 19 and  21) . The last United Kingdom outbreak investigated involved three isolates from two hospital staff members and a member of the family of one of the staff members. These three strains exhibited similar spoligotyping patterns (Fig. 4, lanes 23, 24,  and 26 ). Two isolates from the same town which served as controls were also typed and showed different spoligotype patterns (Fig. 4, lanes 22 and 25) .
The hybridization signals shown in Fig. 4 are weaker than those shown in the other figures because the membrane used for hybridization had already been used 16 times for spoligotyping. Usually, the hybridization signals become too weak after the membrane has been used 20 times.
DISCUSSION
We have developed a method which brings routine detection and DNA typing of M. tuberculosis complex strains within the reach of clinical and public health laboratories. The method is rapid, reproducible, and easy to perform. As a target for in vitro amplification, we used the short, repetitive DR sequence shown to be present uniquely in bacteria of the M. tuberculosis complex. Over 1,000 M. tuberculosis strains have been tested (unpublished data), and no isolate not carrying this multicopy target has been encountered. This is in contrast to the genetic element IS6110, which is absent in certain strains of M. tuberculosis (7, 26) , and therefore DNA from such strains in clinical material may be overlooked by PCR detection with IS6110 as the target.
Compared to traditional IS6110 fingerprinting, the degree of strain differentiation of M. tuberculosis by spoligotyping was lower for strains carrying five or more IS6110 copies and higher for M. tuberculosis complex strains harboring fewer than five IS6110 copies. Work is in progress to sequence the DR region of more strains, and we expect that novel spacers will become available to improve the degree of strain differentiation. However, given the high diversity of M. tuberculosis types observed in this study, we expect that even with the present state of the technique, routine use of spoligotyping may be of great value for the rapid detection and typing of M. tuberculosis. We showed that strains in a recognized outbreak exhibit identical spoligotypes, whereas other isolates are generally different.
Furthermore, we demonstrated that the method can be used to simultaneously detect and type M. tuberculosis present in clinical specimens, such as sputum, tissue, or bronchoalveolar lavages, a procedure that can be performed in less than 2 days. A large variety of clinical materials can be subjected to spoligotyping, and we have even used the method successfully to type M. tuberculosis in sections of 40-year-old paraffin-embedded tissue (21a). Furthermore, the method can be used to detect and type M. tuberculosis present on Ziehl-Neelsen-or auramine-stained microscopy slides (26a) . In this study, spoligotyping was applied to only a limited number of clinical specimens and cultured strains; therefore, further studies are needed to validate the method for use in the diagnosis and epidemiology of tuberculosis. By the use of DNA from clinical material for spoligotyping instead of mycobacterial DNA from cultured cells, one may expect competition of excess foreign DNA with the primers and this may result in less amplified M. tuberculosis DNA. However, because a single primer set is used to amplify a large number of different spacers, all hybridization reactions are expected to be affected equally. Indeed, we have never observed the specific attenuation of any particular hybridization reaction when subjecting clinical samples directly to spoligotyping.
To identify the routes of infection and risk factors for transmission of tuberculosis, all of the M. tuberculosis strains isolated in The Netherlands since 1993 have been subjected to traditional IS6110-based fingerprinting. The preliminary data confirm previous reports (1, 12, 23 ) that most of the recently acquired infections are not detected by traditional contact tracing. Therefore, DNA typing could be helpful to identify nonsuspected sources of transmission. However, we have found that the delay between suspicion of tuberculosis and generation of a DNA fingerprint (usually about 3 months) is a major obstacle to effective exploitation of the predicted links between patients by using RFLP information. Usually, contact tracing is started as soon as a case of infectious tuberculosis is suspected and it is therefore difficult to restart contact tracing months later, when RFLP data become available. The drawback of the delay caused by the currently available typing methods may be overcome by using spoligotyping, which can be performed within 1 or 2 days.
The resurgence of tuberculosis in the United States has been accompanied by alarming outbreaks of M. tuberculosis strains resistant to multiple antimicrobial drugs, mainly among HIVinfected patients (1-3, 6, 8-10, 24) . Due to the increased susceptibility of HIV-infected patients to M. tuberculosis infection and the accelerated progression of the disease (6), rapid diagnosis and typing of the causative mycobacteria may help to effectively control multidrug-resistant tuberculosis. Furthermore, rapid detection and typing of M. tuberculosis are often desirable to distinguish reinfection from reactivation in individual patients who relapse during or after chemotherapy.
An unexpected finding was the ability to discriminate M. bovis from M. tuberculosis by spoligotyping, a distinction which is often difficult to make by traditional bacteriology. All of the 35 M. bovis strains investigated in this study were found to lack the five 3Ј outermost spacers present in the DR locus of M. tuberculosis H37Rv. This characteristic difference has been confirmed for all of about 500 M. bovis and 1,000 M. tuberculosis strains investigated (4a) . By using spoligotyping, we identified M. bovis BCG in a clinical specimen from a 3-year-old patient whose infection apparently reactivated 1 year after vaccination. Because M. bovis generally carries only a single IS6110 element, isolates of this species are difficult to differentiate by IS6110 fingerprinting (5, 29) . The method developed during this study may help to define the animal reservoirs of M. bovis from which transmission to domesticated animals and to humans takes place.
In addition to the speed and simplicity of spoligotyping, the method is time saving and economical because in the "reverse line blot hybridization" technique (16) used here, filters with multiple covalently linked spacer oligonucleotides are used to simultaneously detect and type 43 clinical specimens and these filters can be reused at least 20 times. Furthermore, in contrast to IS6110-based typing, no sophisticated computer software is needed for storage of hybridization images and comparison of large numbers of strains. Because the spoligotype can be expressed as a single word of 43 letters (with an alphabet of three symbols, positive, negative, and indeterminate), a search for matching strains can be done simply by using a word processor. In this study, we occasionally encountered weak hybridization signals, probably due to sequence variation in spacers. Such weak signals may result in ambiguities in interpretation. By using wild cards for weak spots and assignment of a category of indeterminate reactions for weak hybridization signals, one may avoid overlooking strains having identical spoligotypes. In many laboratories, spoligotyping is used either for epidemiologic study of M. bovis infections in animals or for rapid typing of M. tuberculosis isolated in hospitals and other institutions with a high risk of tuberculosis transmission. We are currently building up a database of spoligotypes of strains from different countries. Although the database is still in its infancy, we have already discovered epidemiological links between multipledrug-resistant strains that were unsuspectingly transmitted between various hospitals in different countries (18a) .
